The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

被引：0
|
作者：
M. E. Straver
E. J. Th. Rutgers
S. Rodenhuis
S. C. Linn
C. E. Loo
J. Wesseling
N. S. Russell
H. S. A. Oldenburg
N. Antonini
M. T. F. D. Vrancken Peeters
机构：
[1] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Surgical Oncology
[2] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
[3] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Radiology
[4] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Pathology
[5] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Radiotherapy
[6] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Biostatistics
来源：
Annals of Surgical Oncology | 2010年 / 17卷
关键词：
Trastuzumab; Lobular Carcinoma; Invasive Lobular Carcinoma; Pathological Complete Response; Breast Cancer Subtype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2411 / 2418
页数：7
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy in breast cancer
    Estévez L.G.
    Revista de Oncología, 2004, 6 (5): : 314 - 320
  • [32] Neoadjuvant chemotherapy for breast cancer
    Sapunar, F
    Smith, IE
    ANNALS OF MEDICINE, 2000, 32 (01) : 43 - 50
  • [33] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
    I F Faneyte
    J G Schrama
    J L Peterse
    P L Remijnse
    S Rodenhuis
    M J van de Vijver
    British Journal of Cancer, 2003, 88 : 406 - 412
  • [34] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
    Faneyte, IF
    Schrama, JG
    Peterse, JL
    Remijnse, PL
    Rodenhuis, S
    van der Vijver, MJ
    BRITISH JOURNAL OF CANCER, 2003, 88 (03) : 406 - 412
  • [35] Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy
    Buchholz, TA
    Hill, BS
    Tucker, SL
    Frye, DK
    Kuerer, HM
    Buzdar, AU
    McNeese, MD
    Singletary, SE
    Ueno, NT
    Pusztai, L
    Valero, V
    Hortobagyi, GN
    CANCER JOURNAL, 2001, 7 (05): : 413 - 420
  • [36] Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold
    Kim, Yunju
    Sim, Sung Hoon
    Park, Boram
    Lee, Keun Seok
    Chae, In Hye
    Park, In Hae
    Kwon, Youngmi
    Jung, So-Youn
    Lee, Seeyoun
    Ko, Kyounglan
    Kang, Han-Sung
    Lee, Chan Wha
    Lee, Eun Sook
    CLINICAL BREAST CANCER, 2018, 18 (06) : 459 - +
  • [37] Molecular breast cancer subtypes: relationship with clinicopathological characteristics, efficacy of neoadjuvant chemotherapy and survival
    Babyshkina, N.
    Malinovskaya, E.
    Zavyalova, M.
    Cherdyntseva, N.
    Slonimskaya, E.
    BREAST, 2011, 20 : S41 - S41
  • [38] Different subtypes of metaplastic breast cancer might have different sensitivity to neoadjuvant chemotherapy
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (05): : 2205 - 2205
  • [39] Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population
    Babyshkina, Nataliya
    Malinovskaya, Elena
    Patalyak, Stanislav
    Bragina, Olga
    Tarabanovskaya, Natalia
    Doroshenko, Artem
    Slonimskaya, Elena
    Perelmuter, Vladimir
    Cherdyntseva, Nadejda
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 12
  • [40] The neoadjuvant chemotherapy responses and survival rates of patients with different molecular subtypes of breast cancer
    Zhang, Hui
    Zhang, Xiaoyu
    Jin, Lijun
    Wang, Zunyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4648 - 4656
12345